The breast cancer treatment market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2024, from US$XX.XXX billion in 2018. The breast cancer treatment market will grow during the forecast period owing to the worldwide prevalence of breast cancer. The main reasons for the disease include consumption of alcohol and greater birth weight. Thus, the growing adoption of unhealthy lifestyle conditions among women of different age groups is also fuelling the market growth. Breast cancer survival rates vary greatly worldwide, ranging from 80% or over in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries (source: WHO). Growing awareness regarding self-care and self-management, technological advancements and R&D expenditure are driving the growth of the global breast cancer treatment market in the forecast period. Currently, available treatment includes medications, therapy devices, and technologies in addition to palliative or supportive care.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the breast cancer treatment value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the breast cancer treatment market.
Major industry players profiled as part of the report are Novartis AG, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, AbbVie Inc., and AstraZeneca among others.
The breast cancer treatment market has been analyzed through following segments:
Breast Cancer Surgery
Supportive/ Palliative Care
Middle East and Africa
Key insights offered
What will be the breast cancer treatment market size from 2018 to 2024?
How are the major drivers and restraints affecting the breast cancer treatment market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.